Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent van der Noort

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
The Lancet. Oncology|November 27, 2025
Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 studyLi-Anne H Douma, Vincent van der Noort, Ferry Lalezari, et al.
BJU International|February 25, 2024
Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survivalManon T A Vreeburg, Hielke-Martijn de Vries, Vincent van der Noort, et al.
The Lancet. Oncology|October 16, 2023
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 studyLi-Anne H Douma, Ferry Lalezari, Vincent van der Noort, et al.
Clinical Chemistry|April 12, 2021
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation DetectionDaan C L Vessies, Theodora C Linders, Mirthe Lanfermeijer, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2020
Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?Pieter J M Joosten, Chris Dickhoff, Vincent van der Noort, et al.
Oral Oncology|March 31, 2019
Dilation after laryngectomy: Incidence, risk factors and complicationsJapke F Petersen, Thomas F Pézier, Jolanda M van Dieren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 studyHaiyan Zeng, Lizza E L Hendriks, Willem J A Witlox, et al.
Clinical Nuclear Medicine|December 26, 2015
Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast CancerSuzana Cipriano Teixeira, Bas B Koolen, Wouter V Vogel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 19, 2021
Therapeutic neck dissection in head and neck melanoma patients: Comparing extent of surgery and clinical outcome in two cohortsDanique M S Berger, Danielle Verver, Vincent van der Noort, et al.
AJR. American Journal of Roentgenology|April 9, 2016
Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CTSuzana C Teixeira, José Ferrér Rebolleda, Bas B Koolen, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
The Lancet. Oncology|November 27, 2025
Pembrolizumab plus lenvatinib as second-line treatment in patients with pleural mesothelioma (PEMMELA): cohort 2 of a single-arm, phase 2 studyLi-Anne H Douma, Vincent van der Noort, Ferry Lalezari, et al.
BJU International|February 25, 2024
Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survivalManon T A Vreeburg, Hielke-Martijn de Vries, Vincent van der Noort, et al.
The Lancet. Oncology|October 16, 2023
Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single-arm phase 2 studyLi-Anne H Douma, Ferry Lalezari, Vincent van der Noort, et al.
Clinical Chemistry|April 12, 2021
An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation DetectionDaan C L Vessies, Theodora C Linders, Mirthe Lanfermeijer, et al.
Lung Cancer (Amsterdam, Netherlands)|November 21, 2020
Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?Pieter J M Joosten, Chris Dickhoff, Vincent van der Noort, et al.
Oral Oncology|March 31, 2019
Dilation after laryngectomy: Incidence, risk factors and complicationsJapke F Petersen, Thomas F Pézier, Jolanda M van Dieren, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2023
Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 studyHaiyan Zeng, Lizza E L Hendriks, Willem J A Witlox, et al.
Clinical Nuclear Medicine|December 26, 2015
Additional Prone 18F-FDG PET/CT Acquisition to Improve the Visualization of the Primary Tumor and Regional Lymph Node Metastases in Stage II/III Breast CancerSuzana Cipriano Teixeira, Bas B Koolen, Wouter V Vogel, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 19, 2021
Therapeutic neck dissection in head and neck melanoma patients: Comparing extent of surgery and clinical outcome in two cohortsDanique M S Berger, Danielle Verver, Vincent van der Noort, et al.
AJR. American Journal of Roentgenology|April 9, 2016
Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CTSuzana C Teixeira, José Ferrér Rebolleda, Bas B Koolen, et al.
Pageof 11